Ingestion of prescription drugs by children: an epidemiologic study

W D King1, P A Palmisano

  • 1Southeast Child Safety Institute, Children's Hospital of Alabama, Birmingham 35233.

Southern Medical Journal
|December 1, 1989
PubMed

Insights

Child-resistant packaging reduced product ingestions by 65%, but prescription drug ingestions by children decreased only 36%. This highlights a continuing risk, necessitating targeted caregiver interventions to improve child safety.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatric Safety

Background:

  • The Poison Prevention Packaging Act of 1970 mandated child-resistant containers, significantly reducing accidental ingestions.
  • Despite this, pediatric ingestion of prescription drugs remains a notable cause of morbidity, indicating a gap in current safety measures.

Purpose of the Study:

  • To investigate the factors contributing to the ongoing problem of prescription drug ingestion by children.
  • To provide an epidemiological perspective on the risks associated with pediatric prescription drug exposure.
  • To propose targeted interventions for high-risk caregivers to mitigate these risks.

Main Methods:

  • A descriptive epidemiologic study design was employed.
  • Data were collected from cases reported to a poison control center.

Main Results:

  • While overall product ingestions in child-resistant containers decreased by 65%, prescription drug ingestions by children declined by only 36%.
  • This indicates a persistent and significant risk of prescription drug ingestion among children.

Conclusions:

  • Ingestion of solid prescription drugs by children represents an ongoing, preventable health risk.
  • Interventions should be developed and targeted towards caregivers identified as high-risk to reduce pediatric morbidity.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...